An announcement of FDA Orange book List for New NARCAN Nose Spray Patent
Santa Monica, California, October 27, 2016 (Globe Newswire) - Operant Pharmaceuticals, Inc. ("OPTIC") (OTCQB: OPTION), a special drug company to develop medicinal remedies for the use of substance, Announcement of addiction and eating disorders today, which is now given in the publication of the American Food and Drug Administration (FDA) for NARCAN® Nassal Spray [...]





